Inhibrx Biosciences, Inc. · NASDAQ:INBX

Mark Lappe reported a 6.40% stake in Inhibrx Biosciences, Inc. (Schedule 13D/A)

Event Sep 12, 2024 · Filed Feb 26, 2025

Mark Lappe reported a 6.40% stake in Inhibrx Biosciences, Inc., 925,413 shares, with active intent on Sep 12, 2024. Filed Feb 26, 2025 (Schedule 13D/A).

Stake
6.40%
Shares
925,413
Intent
Active
What changed
Stake changed

The filing in full

HolderStakeShares
Mark Lappe6.40%925,413

Source

View original at SEC

Related